Edition:
United States

Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

16.94USD
10:58am EST
Change (% chg)

$-0.38 (-2.19%)
Prev Close
$17.32
Open
$17.35
Day's High
$17.35
Day's Low
$16.89
Volume
44,231
Avg. Vol
171,938
52-wk High
$21.99
52-wk Low
$12.25

Latest Key Developments (Source: Significant Developments)

Diplomat to acquire LDI Integrated Pharmacy Services
Wednesday, 15 Nov 2017 04:15pm EST 

Nov 15 (Reuters) - Diplomat Pharmacy Inc :Diplomat to acquire LDI Integrated Pharmacy Services.Diplomat to acquire LDI Integrated Pharmacy Services.Diplomat Pharmacy Inc - ‍will pay LDI $515 million cash and approximately $80 million in diplomat common stock​.Diplomat Pharmacy Inc - ‍LDI is expected to generate approximately $388 million in revenue and $41 million in adjusted EBITDA in 2017​.Diplomat Pharmacy Inc - ‍cash portion of acquisition is expected to be funded by diplomat's new $795 million senior secured credit facility​.  Full Article

Diplomat Pharmacy announces 3rd quarter financial results
Monday, 6 Nov 2017 04:18pm EST 

Nov 6 (Reuters) - Diplomat Pharmacy Inc :Diplomat announces 3rd quarter financial results.Q3 adjusted earnings per share $0.25.Q3 earnings per share $0.01.Q3 revenue $1.125 billion versus I/B/E/S view $1.16 billion.Q3 earnings per share view $0.15 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $0.82 to $0.87.Sees FY 2017 earnings per share $0.15 to $0.20.Sees FY 2017 revenue $4.4 billion to $4.6 billion.FY2017 earnings per share view $0.75, revenue view $4.52 billion -- Thomson Reuters I/B/E/S.Diplomat Pharmacy Inc - ‍resolved arbitration with CVS and have transitioned from a PSAO contract to a direct contract with CVS​.  Full Article

Diplomat Pharmacy to acquire Pharmaceutical Technologies Inc
Monday, 6 Nov 2017 04:15pm EST 

Nov 6 (Reuters) - Diplomat Pharmacy Inc :Diplomat Pharmacy - entered agreement to acquire Pharmaceutical Technologies Inc, doing business as National Pharmaceutical Services.Diplomat Pharmacy - under the terms of the agreement, Diplomat will pay NPS $31 million cash and $16 million in Diplomat common stock‍​.  Full Article

Diplomat Pharmacy - ‍now dispensing opioid-overdose antidote naloxone to Michigan residents​
Tuesday, 15 Aug 2017 04:30pm EDT 

Aug 15 (Reuters) - Diplomat Pharmacy Inc :Diplomat Pharmacy Inc - ‍now dispensing opioid-overdose antidote naloxone to Michigan residents​​.  Full Article

Diplomat Pharmacy Q2 adjusted earnings per share $0.25
Monday, 7 Aug 2017 04:18pm EDT 

Aug 7 (Reuters) - Diplomat Pharmacy Inc :Diplomat announces 2nd quarter financial results.Q2 adjusted earnings per share $0.25.Q2 earnings per share $0.05.Q2 earnings per share view $0.15 -- Thomson Reuters I/B/E/S.Sees fy 2017 adjusted earnings per share $0.71 to $0.79.Sees fy 2017 earnings per share $0.15 to $0.23.Sees fy 2017 revenue $4.3 billion to $4.6 billion.Q2 revenue $1.126 billion versus i/b/e/s view $1.14 billion.Fy2017 earnings per share view $0.65, revenue view $4.57 billion -- Thomson Reuters I/B/E/S.  Full Article

Diplomat Pharmacy Q1 revenue $1.079 billion
Monday, 8 May 2017 04:20pm EDT 

May 8 (Reuters) - Diplomat Pharmacy Inc ::Diplomat announces 1st quarter financial results.Q1 adjusted earnings per share $0.19.Q1 earnings per share $0.06.Q1 earnings per share view $0.15 -- Thomson Reuters I/B/E/S.Sees FY 2017 earnings per share $0.09 to $0.23.Sees FY 2017 revenue $4.3 billion to $4.7 billion.Q1 revenue $1.079 billion versus i/b/e/s view $1.08 billion.Diplomat Pharmacy Inc- for full-year 2017, we are maintaining our previous financial guidance.Fy2017 earnings per share view $0.64 -- Thomson Reuters I/B/E/S.  Full Article

Diplomat acquires WRB Communications
Monday, 8 May 2017 04:10pm EDT 

May 8 (Reuters) - Diplomat Pharmacy Inc ::Diplomat acquires WRB Communications.Diplomat Pharmacy Inc - under terms of agreement, diplomat is paying WRB $24.5 million cash and $4.5 million of diplomat common stock.Diplomat - under terms of a 2-year contingent earnout, WRB can earn an additional payout of up to $1 million based upon achievement of EBITDA-based targets.  Full Article

Diplomat Pharmacy on March 31,co, units, Celgene entered into pharmacy distribution, services agreement to be effective July 1, 2017
Thursday, 13 Apr 2017 08:15am EDT 

Celgene Corp : Diplomat Pharmacy Inc - on March 31,co, units, Celgene Corp entered into a pharmacy distribution and services agreement to be effective July 1, 2017 . Diplomat pharmacy - on effective date, agreement will replace co's current agreement with Celgene, as amended, which is set to expire on June 30, 2017 . Diplomat pharmacy - agreement sets forth terms and conditions on which company will purchase specialty drugs from Celgene and provide certain services .Diplomat Pharmacy - under terms services to be provided in connection with dispensing prescriptions for specialty drugs after expiration of current deal.  Full Article

Diplomat partners with Corizon Health to dispense specialty drugs
Wednesday, 12 Apr 2017 04:30pm EDT 

Diplomat Pharmacy Inc - : Diplomat partners with Corizon Health to dispense specialty drugs .Diplomat Pharmacy Inc- three-year agreement, effective march 17, 2017, supports specialty pharmacy services across 25 states.  Full Article

Diplomat appoints Atul Kavthekar as new CFO
Tuesday, 11 Apr 2017 08:00am EDT 

Diplomat Pharmacy Inc : Diplomat appoints new Chief Financial Officer . Diplomat Pharmacy Inc - Appointed Atul Kavthekar as chief financial officer and treasurer, effective May 1, 2017 .Diplomat Pharmacy Inc - Prior to Diplomat, Kavthekar served as CFO of Livingsocial, Inc., an e-commerce retailer.  Full Article

Diplomat Pharmacy plunges as investors fret over rapid PBM push

Shares of Diplomat Pharmacy Inc tumbled 20 percent on Thursday after the company acquired a second pharmacy benefit manager in less than a month, sparking concerns it is expanding into a business that is under heightened regulatory scrutiny.